CIMAvax-EGF: Toward long-term survival of advanced NSCLC

Review

Abstract: Lung cancer remains one of the leading causes of cancer-related deaths. Non–small cell lung cancer (

Palabras claves:

cancer vaccine, CIMAvax-EGF, Clinical trial, EGF, Epidermal growth factor receptor, immunotherapy, non–small cell lung cancer

Autores:

Camilo Rodríguez, Carmen Elena Viada, Lage Davila A., Mazorra Z., Neninger Vinageras E., Saavedra Hernández D., Tania Crombet

Fuentes:

scopus